• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    PassPort Tech Announces Positive Results of Zolmitriptan for the Treatment of AM

    PR NEWSWIRE

    PassPort Initiated Ph I Trial of Zolmitriptan Transdermal Microporation System

    PR NEWSWIRE

    Migraine patch developer Zosano Pharma suspends program

    BIZJOURNALS

    FDA Rejects Zosano`s Application For Zolmitriptan Microneedle System Again

    BENZINGA

    Padagis Announces The First-to-Market Launch Of An AB Rated Generic Zomig

    PRNEWSWIRE

    Padagis Launches AB Rated Generic Version Of Zomig Nasal Spray

    PRNEWSWIRE

    Zosano evaluates C213 in Phase II/III cluster headache trial

    CLINICALTRIALSARENA

    Zosano Pharma Initiates Phase 2/3 Clinical Study in Second Late Stage Program

    BIOSPACE

    Zosano launches Phase 2/3 study of zolmitriptan for cluster headache

    SEEKINGALPHA

    Orchid Hlthcare’S Generic Zolmitriptan Receives Approval In US

    FDA

    AstraZeneca sells 3 drugs for $350M upfront

    BIOPHARMADIVE

    AstraZeneca hands over some rights to Nexium, Vimovo to Grunenthal as it plots turnaround

    ENDPTS

    Zosano Pharma Enters Lease Agreement With Trinity Capital

    GLOBENEWSWIRE

    Amneal Announces Favorable Ruling Regarding Patent Validity for Zomig®

    PR NEWSWIRE

    Appco Pharma’s Generic Zolmitriptan Receives Approval In US

    FDA

    AZ divests migraine drug to Grunenthal

    PHARMA TIMES

    Impax Announces Favorable Ruling Regarding Patent Validity for Zomig Nasal Spray

    PR NEWSWIRE

    PLD Acquisitions Generic Zolmitriptan Receives Approval In US

    FDA

    Alembic Pharma gets US FDA nod for anti-migraine drug

    ECONOMIC TIMES

    Alembic`s Generic Zolmitriptan Receives Approval In US

    FDA

    Ajanta Pharma gets USFDA nod for migraine pain relief drug

    ECONOMIC TIMES

    USFDA Approves Aurobindo’s ANDA for Zomig

    TWOFOUR INSIGHT

    Aurobindo Pharma`s Generic Zolmitriptan approved in US as treatment of migraine

    FDA

    Macleods` Generic Zolmitriptan (2.5mg) approved in US for Migraines

    FDA

    Alembic Pharms` Generic Zolmitriptan approved in US for Migraines

    FDA

    Astrazeneca`s Zomig (Zolmitriptan) Receives supplemental Approval in US For Migraine

    FDA

    Impax Laboratories Expects More M A After Latest Deal Closes

    THE STREET

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.